N-TEC

DRUG3 trials

Sponsors

Universitaetsspital Basel, University Hospital, Basel, Switzerland

Conditions

Patellofemoral OsteoarthritisPatellofemoral osteoarthritis

Phase 2

Treatment of Patellofemoral Osteoarthritis With Engineered Cartilage.

RecruitingNCT06163573

University Hospital, Basel, SwitzerlandPatellofemoral Osteoarthritis

Start: 2024-06-06End: 2029-09-01Target: 75Updated: 2026-09-10

Treatment of patellofemoral osteoarthritis with nasal chondrocyte-based engineered cartilage implantation in a randomized, controlled, multi-center phase II clinical trial

RecruitingCTIS2023-508640-21-00

Universitaetsspital BaselPatellofemoral osteoarthritis

Start: 2025-09-22Target: 30Updated: 2025-09-02

Randomized, controlled, multi-center phase II clinical trial for the treatment of patellofemoral osteoarthritis with nasal chondrocyte-based tissue engineered cartilage implantation vs current standard of care (ENCANTO)

RecruitingCTIS2024-513683-25-00

Universitaetsspital BaselPatellofemoral osteoarthritis

Start: 2025-06-30Target: 122Updated: 2025-06-17

Related Papers

Treatment of patellofemoral osteoarthritis with nasal chondrocyte-based engineered cartilage implantation in a randomised, controlled, multicentre phase II clinical trial: protocol for a randomised controlled trial

BMJ Open2025-08-011 citations